Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%
March 11, 2024 06:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, March 11, 2024 (GLOBE NEWSWIRE) -- The Global Recombinant Vaccine Market Size is to Grow from USD 8.2 Billion in 2022 to USD 24.9 Billion by 2032, at a Compound Annual...
SoftServe Achieves AWS Generative AI Competency as Inaugural Launch Partner
March 07, 2024 08:35 ET
|
SoftServe
AUSTIN, Texas, March 07, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced that it has become an inaugural partner to obtain the Amazon Web...
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
March 06, 2024 15:30 ET
|
ACTG
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures
Vaccine Adjuvants Market projected to reach USD 5.6 Billion by 2030, growing at a CAGR of 13.1% during the forecast period of 2023-2030 - pronounced by MarketDigits in its recent study
February 05, 2024 04:00 ET
|
PIONEERING MARKETDIGITS CONSULTING AND ADVISORY PRIVATE LIMITED
Richmond, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to a research report "Vaccine Adjuvants Market”, by Product Type (Aluminum Adjuvants, Emulsion Adjuvants, Pathogen Components, Saponin-Based...
Cytomegalovirus Infections Market to Exhibit Moderate Growth by 2032, Evaluates DelveInsight | Leading Companies - ModernaTX, Inc., Merck Sharp & Dohme LLC, GlaxoSmithKline, AlloVir
January 29, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cytomegalovirus Infections Market to Exhibit Moderate Growth by 2032, Evaluates DelveInsight | Leading Companies - ModernaTX, Inc., Merck Sharp &...
CryoMass Announces Non-Dilutive Financing Agreement
January 29, 2024 07:10 ET
|
Cryomass Technologies
CryoMass Announces Non-Dilutive Financing Agreement
Vaccine Adjuvants Industry Forecast to 2034: A $7.36 Billion Market Opportunity, Dominated by Merck & Co, Thermo Fisher Scientific, and Pacific GeneTech
January 24, 2024 14:18 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global vaccine...
Global Agricultural Waste Water Treatment Market Size is Estimated to Reach USD 3.13 billion by 2030, Growing at a CAGR of 4.12%: Straits Research
January 16, 2024 09:05 ET
|
Straits Research
New York, United States, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Treatment of wastewater or recycling of water can act as an alternative resource to meet the demand for freshwater resources. Water...
Bion’s New Patent Expands Coverage to Industrial and Municipal Waste Streams
January 16, 2024 08:00 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef, was...
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer
January 08, 2024 08:01 ET
|
Vera Therapeutics
BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for...